Cargando…
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
Mesenchymal stem cell (MSC)-derived secretome demonstrated therapeutic effects like those reported after MSCs transplantation. MSC-derived secretome may avoid various side effects of MSC-based therapy, comprising undesirable differentiation of engrafted MSCs and potential activation of the allogenei...
Autores principales: | d’Angelo, Michele, Cimini, Annamaria, Castelli, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432166/ https://www.ncbi.nlm.nih.gov/pubmed/32718092 http://dx.doi.org/10.3390/ijms21155241 |
Ejemplares similares
-
Neuroprotective effects of human amniotic fluid stem cells‐derived secretome in an ischemia/reperfusion model
por: Castelli, Vanessa, et al.
Publicado: (2020) -
The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
por: Castelli, Vanessa, et al.
Publicado: (2020) -
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
por: D’Egidio, Francesco, et al.
Publicado: (2023) -
Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models
por: Antonosante, Andrea, et al.
Publicado: (2023) -
The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
por: Castelli, Vanessa, et al.
Publicado: (2021)